Atom Investors LP Biocryst Pharmaceuticals Inc Transaction History

Atom Investors LP

  • $906 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$7.37 - $13.61 $239,178 - $441,685
-32,453 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$3.37 - $8.61 $59,490 - $151,992
17,653 Added 119.28%
32,453 $242,000
Q3 2020

Nov 13, 2020
BUY
$3.43 - $5.53 $50,764 - $81,844
14,800 New
14,800 $51,000

Others Institutions Holding BCRX

# of Institutions
278
Shares Held
171M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.39B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email